Applicant, as named in the Orange Book

Edenbridge Pharms

Next listed expiry: Zubsolv on 18 Sep 2032. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Zubsolv NDA 204242 · 6 strengths buprenorphine hydrochloride; naloxone hydrochloride	buprenorphine hydrochloride; naloxone hydrochloride	18 Sep 2032 patent	patent

Zubsolv · Generic approved · ANDA 219727, Ascent Pharms IncApproved 15 Dec 2025Detected 25 Oct 2026